Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials

• Autors principals: Jingjing Wei (Autor), Bin Li (Autor), Xinlu Wang (Autor), Xingyuan Li (Autor), Yucai Hu (Autor), Lijie Qiao (Autor), Cheng Zhou (Autor), Peng Yu (Autor), Tianqing Sang (Autor), Mingjun Zhu (Autor), Yongxia Wang (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Objective: Qili Qiangxin Capsule (QQC), a Chinese patent medicine, is clinically effective in treating dilated cardiomyopathy (DCM). However, the meta-analysis of QCC combined with conventional western medicine (CWM) on DCM remains unexplored. This study aimed to systematically evaluate the efficacy...